Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Tisagenlecleucel Continues to Impress in DLBCL

December 10th 2017

The CAR T-cell therapy tisagenlecleucel (Kymriah) achieved an overall response rate of 53.1% in adult patients with relapsed/refractory diffuse large B-cell lymphoma.

Frontline Brentuximab Vedotin With AVD Bests ABVD for Advanced HL

December 10th 2017

The phase III ECHELON-1 study in Hodgkin lymphoma compared the use of A+AVD with standard chemotherapy of doxorubicin, bleomycin, vinblastine, and dacarbazine.

Alternative Agent Shows Clinical Activity in Patients With Advanced Systemic Mastocytosis

December 10th 2017

Treatment using BLU-285 (Avapritinib) induced clinically significant activity in patients with an advanced or aggressive form of systemic mastocytosis, according to data from an ongoing phase I trial.

Dr. Davids on Checkpoint Blockade Inhibition in Hematologic Malignancies After Stem Cell Transplant

December 10th 2017

Matthew S. Davids, MD, Associate Director, Dana-Farber Cancer Institute Center for Chronic Lymphocytic Leukemia, discusses a study that explored optimizing checkpoint blockade as a treatment for relapsed hematologic malignancies after allogenic hematopoietic cell transplantation.

Case Study 2: Options for Biochemically Relapsed MM

December 8th 2017

Case Study 2: An Elderly Patient With Multiple Myeloma

December 8th 2017

Case Study 1: The Value of KRd in Multiple Myeloma

December 8th 2017

Case Study 1: Treating MM After RVd and Transplant

December 8th 2017

Case Study 1: Follow-Up Strategies for Multiple Myeloma

December 8th 2017

Case Study 1: A Diagnosis of Stage II Multiple Myeloma

December 8th 2017

Multiple Myeloma: Second Relapse and Beyond

December 8th 2017

Multiple Myeloma: Considerations in Treating Relapse

December 8th 2017

Multiple Myeloma: Using Novel Therapies at Relapse

December 8th 2017

Multiple Myeloma: Understanding and Treating Progression

December 8th 2017

Maintenance Therapy's Value in Multiple Myeloma

December 8th 2017

Multiple Myeloma: Optimizing Approaches to Transplant

December 8th 2017

The Current Role of Transplant in Multiple Myeloma

December 8th 2017

Understanding Treatment Planning in Multiple Myeloma

December 8th 2017

Strategies for Upfront Therapy in Multiple Myeloma

December 8th 2017

Multiple Myeloma: Upfront Therapy and Longer Remissions

December 8th 2017